ADAPTIMMUNE THERAPEUTICS PLC (ADAP) Files An 8-K Other Events
Item 8.01. Other Events.
On November11, 2016, Adaptimmune Therapeutics plc (the Company)
issued a press release announcing the presentation of data at the
2016 Society for Immunotherapy for Cancer (SITC) annual meeting.
The posters summarized: (1)preclinical data from the Companys
wholly-owned MAGE-A4 SPEAR (Specific Peptide Enhanced Affinity
Receptor) T-cells; (2)preclinical data from the Companys second
generation SPEAR T-cell, which is engineered to overcome
immunosuppression in the tumor microenvironment by blocking the
effects of transforming growth factor Beta (TGF-Beta); and (3)a
single-patient case study from the Companys ongoing synovial
sarcoma study. The press release is furnished as Exhibit99.1 to
this report and is incorporated by reference herein.
On November11, 2016, the Company also issued a press release
announcing an oral presentation with updated data on its study of
NY-ESO SPEAR T-cells in its ongoing synovial sarcoma trial at the
2016 Connective Tissue Oncology Society (CTOS) annual meeting.
This presentation included an update to Cohort 1 median survival
data. The press release is furnished as Exhibit99.2 to this
report and is incorporated by reference herein.
The information in Item8.01 of this Form8-K (including the
attached Exhibit99.1 and the attached Exhibit99.2) shall not be
deemed filed for purposes of Section18 of the Securities Exchange
Act of 1934, as amended, or otherwise subject to the liabilities
of that section, nor shall it be deemed incorporated by reference
under the Securities Act of 1933, as amended, except as expressly
set forth by specific reference in such a filing, regardless of
any general incorporation language in any such filing, unless the
Company expressly sets forth in such filing that such information
is to be considered filed or incorporated by reference therein.
Item 9.01 Financial Statements and
Exhibits.
(d) Exhibits. The following exhibits are furnished as part of
this Report on Form8-K:
|
ExhibitNo. |
|
DescriptionofExhibit |
|
99.1 |
Press Release concerning presentation of data at SITC |
|
|
99.2 |
Press Release concerning presentation of data at CTOS |
About ADAPTIMMUNE THERAPEUTICS PLC (ADAP)